Hospital, Manufacturing, Patients and Referral

Search:

DAY

WEEK

MONTH

YEAR

Select your country:
Sign up | Log in

Hospital

Manufacturing

Patients

Referral

The 340B Showdown: HRSA Proceeds Towards Enforcement Despite Litigation

FDA Law

SEPTEMBER 29, 2021

The 340B program, authorized under Section 340B of the Public Health Services Act and administered by HRSA, imposes a ceiling price on pharmaceutical manufacturer sales to “covered entities,” which are certain health clinics that receive federal funding and certain types of safety net hospitals to provide them drugs at lower prices.

Manufacturing

Manufacturing Government Referral Provider

Primary care clinics changes in abortion care after participation in the 2022-23 ExPAND Mifepristone Learning Collaborative [Women's health]

Annals of Family Medicine

NOVEMBER 20, 2024

2) Those unable to provide abortion care will: a) learn about evidence-based use of mifepristone for abortion care; b) implement supportive referrals for patients seeking abortion care. Setting and Population Studied: The ExPAND 2022-23 cohort supported 3 clinics in the Midwest (1 FQHC, 2 community hospital clinics).

Primary Care

Primary Care Clinic Referral Provider

Primary Care Digest

The 340B Showdown: HRSA Proceeds Towards Enforcement Despite Litigation

Primary care clinics changes in abortion care after participation in the 2022-23 ExPAND Mifepristone Learning Collaborative [Women's health]

Stay Connected